clopidogrel and Atherogenesis

clopidogrel has been researched along with Atherogenesis in 100 studies

Research

Studies (100)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	42 (42.00)	29.6817
2010's	41 (41.00)	24.3611
2020's	17 (17.00)	2.80

Authors

Authors	Studies
Hu, Y; Li, X; Shi, Q; Zhang, J	1
Du, Y; He, L; Liu, Q; Wang, H; Wang, J; Xu, J; Xu, X	1
Huang, T; Wan, H; Wu, Q; Wu, T; Yang, P; Zhang, H	1
Kimura, K; Suzuki, K	1
Angiolillo, DJ; Been, L; Franchi, F; Maaliki, N; Ortega-Paz, L; Pineda, AM; Rivas, A; Rollini, F; Soffer, D; Suryadevara, S; Zenni, M; Zhou, X	1
Amarenco, P; Bath, PM; Chen, W; Gao, Y; Han, S; Jing, J; Johnston, SC; Li, H; Liu, L; Meng, X; Pan, Y; Wang, C; Wang, T; Wang, Y; Yang, Y; Zhao, X	1
Li, MH; Liu, J; Wang, JT; Wei, YN	1
Chen, X; Jiang, L; Liu, C; Su, J; Zheng, N; Zhong, J	1
Bae, HJ; Cha, JK; Cho, KH; Cho, YJ; Choi, JC; Choi, JK; Choi, KH; Gorelick, PB; Gwak, DS; Han, MK; Hong, JH; Hong, KS; Jeong, HB; Kang, CH; Kang, J; Kang, K; Kim, BJ; Kim, C; Kim, DE; Kim, DH; Kim, JG; Kim, JT; Kim, JY; Kim, WJ; Kim, YS; Kwon, DH; Kwon, JH; Lee, BC; Lee, J; Lee, K; Lee, M; Lee, SH; Lee, SJ; Norrving, B; Oh, MS; Park, H; Park, HK; Park, JM; Park, KY; Park, MS; Park, SS; Park, TH; Shin, DI; Sohn, SI; Yu, KH; Yum, KS	1
Bath, PM; Claiborne Johnston, S; Jiang, Y; Jing, J; Li, H; Li, Z; Liu, L; Meng, X; Wang, A; Wang, Y; Xie, X; Xu, Q; Zhao, X	1
Ahmad, FS; Anderson, RD; Benziger, CP; Effron, MB; Farrehi, P; Girotra, S; Gupta, K; Harrington, RA; Hernandez, AF; Jain, SK; Jones, WS; Kripalani, S; Marquis-Gravel, G; Muñoz, D; Polonsky, TS; Roe, MT; Rothman, RL; Stebbins, A; Whittle, J; Wruck, L	1
Cannata, F; Cao, D; Chiarito, M; Condorelli, G; De Caterina, R; Ferrante, G; Godino, C; Panico, C; Regazzoli, D; Reimers, B; Sanz-Sánchez, J; Stefanini, GG; Sturla, M	1
Chen, X; Gong, S; Hu, C; Hu, X; Li, L; Pei, T; Yang, J; Zhang, L	1
Abe, K; Ikeda, Y; Kitagawa, K; Kitazono, T; Matsumoto, M; Minematsu, K; Nagao, T; Nagata, I; Nanto, S; Nishikawa, M; Ogawa, A; Shirai, T; Tanahashi, N; Toyoda, K; Uchiyama, S; Yamagami, H	1
Fang, Q; Jiang, J; Li, L; Liu, M; Liu, Y; Wang, D; Zhang, Q; Zhao, H	1
Olie, RH; Spronk, HMH; Ten Cate, H; van der Meijden, PEJ	1
Åkerblom, A; Aukrust, P; Becker, RC; Gregersen, I; Halvorsen, B; Himmelmann, A; James, SK; Johansen, HT; Kontny, F; Lakic, TG; Lindbäck, J; Lunde, NN; Michelsen, AE; Ryeng Skagen, K; Siegbahn, A; Skjelland, M; Solberg, R; Storey, RF; Ueland, T; Wallentin, L	1
Jung, JM; Kim, SU; Kwon, DY; Park, JW; Park, MH	1
Roditi, G; Stuart, W; Tan, AB	1
Aboyans, V; Anand, SS; Bauersachs, R; Bosch, J; Debus, ES; Eikelboom, JW; Mazzolai, L; Nehler, M; Nikol, S; Pastori, D; Patel, MR; Ricco, JB; Tanguay, JF; Verhamme, P; Violi, F	1
Bae, HJ; Cha, JK; Cho, YJ; Choi, JC; Choi, KH; Gorelick, PB; Han, MK; Hong, JH; Hong, KS; Kang, K; Kim, BJ; Kim, D; Kim, DE; Kim, DH; Kim, JG; Kim, JT; Kim, WJ; Kwon, JH; Lee, BC; Lee, J; Lee, JS; Lee, KB; Lee, SJ; Nah, HW; Oh, MS; Park, JM; Park, TH; Ryu, WS; Shin, DI; Sohn, SI; Yu, KH	1
Chunhacha, P; Fujise, K; Halim, H; Pinkaew, D; Sinthujaroen, P; Thiagarajan, P	1
Asseburg, C; Giannitsis, E; Katus, H; Theidel, U	1
Hatzidakis, A; Kassimis, G; Krokidis, M; Spiliopoulos, S	1
Acharji, S; Kaluski, E; Lakshmanadoss, U; Rudzinski, W; Stapleton, DD	1
Angiolillo, DJ; Bauer, D; Bhatt, DL; Ferreiro, JL; Ueno, M	1
Angiolillo, DJ; Bass, TA; Bhatti, M; Cho, JR; Darlington, A; Degroat, C; Desai, B; Ferrante, E; Ferreiro, J; Franchi, F; Guzman, LA; Muniz-Lozano, A; Patel, R; Rollini, F; Tello-Montoliu, A; Zenni, MM	1
Ajeena, IM; Hadi, NR; Mohammad, BI; Sahib, HH	1
Francis, SE; Judge, HM; Steiner, T; Storey, RF; West, LE	1
Durstberger, M; Eichelberger, B; Gremmel, T; Kopp, CW; Koppensteiner, R; Panzer, S	1
Chi, L; Liao, D; Lin, J; Wang, C; Yi, X; Zhang, B	1
Ensminger, SM; Gebhardt, J; Heim, C; Jacobi, J; Ramsperger-Gleixner, M; Weyand, M	1
Davis, KA; Dietrich, E; Miyares, MA	1
Dobrovolsky, AB; Guskova, EV; Laguta, PS; Panchenko, EP; Storozhilova, AN; Titaeva, EV; Yarovaya, EB	1
Bae, HJ; Cha, JK; Chang, DI; Cho, KH; Cho, YJ; Choi, JC; Hong, KS; Kang, DW; Kim, DE; Kim, EG; Kim, GM; Kim, HY; Kwon, SU; Lee, J; Lee, KB; Lee, SH; Lee, SJ; Lee, YS; Park, JM; Park, KY; Rha, JH; Sohn, CH; Sohn, SI; Yoon, BW; Yu, KH	1
Álvarez Cubero, MJ; Cabeza Barrera, J; Carmona-Sáez, P; Dávila-Fajardo, CL; Díaz-Villamarín, X; Fernández-Quesada, F; Martínez-González, LJ; Salmerón-Febres, LM; Sánchez-Ramos, J	1
Chen, WC; Cheng, JS; Hsu, PI; Kao, SS; Lai, KH; Liu, CP; Tsai, KW; Tsai, TJ; Tsay, FW; Wang, HM; Wu, DC	1
Hohlfeld, T; Zimmermann, N	1
Klauss, V; Krötz, F; Sohn, HY	1
Annapurna, A; Reddy, YN; Srinivas, M	1
Mohler, ER	1
Faxon, DP; Freedman, JE	1
Hussein, A; Irani, F; Kasmani, R; Mohan, G	1
Afek, A; George, J; Keren, G; Kogan, E; Maysel-Auslender, S; Mor, A; Regev, E; Rubinstein, A	1
Bhatt, DL; Easton, JD; Fox, KA; Hankey, GJ; Mak, KH; Shao, M; Topol, EJ	1
Biller, J	1
Rees, C; Spinler, SA	1
Alban, S; Dingermann, T	1
Husted, S; van Giezen, JJ	1
Armstrong, M; Cannon, CP; Emanuelsson, H; Heptinstall, S; Husted, S; Lawrance, R; Melissa Thornton, S; Storey, RF; Wickens, M	1
Gomez, CR; Qureshi, AI	1
Cable, G; Willerson, JT; Yeh, ET	1
Angiolillo, DJ; Ferreiro, JL	1
Gurbel, PA; Tantry, US	1
Feng, L; Jiang, J; Li, M; Ren, H; Zhang, Y; Zhu, X	1
Akgün, T; Can, MM; Karabay, CY; Kaymaz, C; Ozveren, O; Serebruany, V; Tanboğa, IH; Tokgöz, HC; Türkyilmaz, E	1
Heeg, BM; Herlitz, J; Logman, JF; van Hout, BA	1
Givol, N; Halkin, A	1
Hsu, PI; Lai, KH; Liu, CP	1
Laine, L	1
Christiansen, CF; Lash, TL; Riis, AH; Schmidt, M; Sørensen, HT	1
Bhatt, DL; Brennan, DM; Easton, DJ; Fox, KA; Hamm, CW; Hankey, GJ; Johnston, SC; Mak, KH; Montalescot, G; Steinhubl, SR; Topol, EJ; Weber, M	1
Bouman, HJ; Breet, NJ; Hackeng, CM; Harmsze, AM; Kelder, JC; ten Berg, JM; van Werkum, JW	1
Gehr, NR; Johannesen, NL; Kristensen, SR; Madsen, EH; Schmidt, EB	1
Hirata, K; Momose, A; Nakajima, K; Sasaki, N; Shinohara, M; Takeda, M; Tawa, H; Yamashita, T	1
Berger, JS; Berger, PB; Bhatt, DL; Fox, KA; Hacke, W; Lincoff, AM; Montalescot, G; Shao, M; Steg, PG; Steinhubl, SR; Topol, EJ	1
Carpio, A; Chae, YK; Gupta, S; Khemasuwan, D; Lucca, AB; Mora, JI; Neagu, S; Valsecchi, ME; Yun, JH	1
Daemen, MJ; Gabriels, K; Gijbels, MJ; Heeneman, S; Hoving, S; Pol, JF; Russell, NS; Stewart, FA; te Poele, JA	1
Kang, DW; Kim, BJ; Kim, JS; Kwon, SU; Lee, SW; Park, SW	1
Berger, PB; Bhakta, N; Bhatt, DL; Cacoub, P; Creager, MA; Eikelboom, JW; Emison, ES; Flather, MD; Fox, KA; Hacke, W; Kottke-Marchant, K; Lincoff, AM; Mak, KH; Mehta, SR; Montalescot, G; Murugesan, G; Paré, G; Simonsen, KL; Steg, PG; Steinhubl, SR; Topol, EJ	1
Abrigo, J; Ahuja, AT; Leung, TW; Ng, N; Siu, DY; Soo, YO; Wong, LK; Yu, S	1
Fragoulakis, V; Kourlaba, G; Maniadakis, N	1
Reinhart, WH	1
Boettel, J; Breuel, H; Kabisch, B; Lösche, W; Otto, GP; Sossdorf, M; Winning, J	1
Chen, JL; Gu, Q; Ruan, YM	1
Andre, P; Conley, PB; Phillips, DR; Sinha, U	1
Claussen, CD; Dinkelborg, LM; Duda, SH; Laule, M; Muschick, P; Reddig, F; Tepe, G; Tielemans, H; Wehrmann, M	1
Emanuelsson, H; Heptinstall, S; Husted, S; Peters, G; Sandset, PM; Wickens, M	1
Algayres, JP; Baranger, B; Coutant, G; Defuentes, G; Lecoules, S; Vedrine, L	1
Hiatt, WR; Krantz, MJ	1
Lutsep, HL	1
Casella, G; Di Pasquale, G; Greco, C; Pallotti, MG; Pavesi, PC; Perugini, E	1
Amarenco, P; Davis, SM; Donnan, GA; Michel, P; Röther, J	1
Barnett, HJ; Norris, JW	1
Li, M; Ren, H; Zhang, Y; Zhu, X	1
Liao, JK	1
Fitzgerald, DJ; Maree, AO	1
Bhatt, DL; Meadows, TA	1
Brown, MT; Kikano, GE	1
Badimon, JJ; Bhatt, DL; Herbert, JM; Lüscher, TF; Steinhubl, SR	1
Anand, S; Budaj, A; Cina, C; Crowell, R; Eikelboom, J; Gosselin, G; Guzman, R; Keltai, M; Liu, L; Pogue, J; Sussex, B; Xie, C; Yusuf, S	1
Bhatt, DL; Boden, WE; Brennan, DM; Flather, MD; Fox, KA; Hacke, W; Mak, KH; Montalescot, G; Pearson, TA; Steg, PG; Steinhubl, SR; Topol, EJ; Wang, TH	1
Fisher, M; Johns, T	1
Berger, K; Diener, HC; Hessel, F; Kreuzer, J; Smala, A	1
Hankey, GJ	1
Koellnberger, M; Konrad, I; Lorenz, R; Massberg, S; Orschiedt, L; Sauer, S; Schulz, C; Walter, U	1
Ellahham, S	1
Comerota, AJ; Thakur, S	1
Kapoor, JR	1
Kim, S; Lipsitz, EC	1

Reviews

29 review(s) available for clopidogrel and Atherogenesis

Article	Year
Efficacy and Safety of Cilostazol for Atherosclerosis: A Meta-analysis of Randomized Controlled Trials. Journal of cardiovascular pharmacology, 2022, 03-01, Volume: 79, Issue:3 Topics: Aspirin; Atherosclerosis; Cilostazol; Clopidogrel; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Tetrazoles	2022
Prophylactic Efficacy and Safety of Antithrombotic Regimens in Patients with Stable Atherosclerotic Cardiovascular Disease (S-ASCVD): A Bayesian Network Meta-Regression Analysis. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2023, Volume: 23, Issue:3 Topics: Aspirin; Atherosclerosis; Bayes Theorem; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Ischemic Stroke; Myocardial Infarction; Network Meta-Analysis; Platelet Aggregation Inhibitors; Regression Analysis; Rivaroxaban; Stroke; Ticagrelor	2023
Monotherapy with a P2Y Lancet (London, England), 2020, 05-09, Volume: 395, Issue:10235 Topics: Aged; Aspirin; Atherosclerosis; Cerebrovascular Disorders; Clopidogrel; Coronary Disease; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Risk Assessment; Secondary Prevention; Stroke; Ticagrelor; Ticlopidine	2020
Management of Patients with Asymptomatic and Symptomatic Carotid Artery Disease: Update on Anti-Thrombotic Therapy. Thrombosis and haemostasis, 2019, Volume: 119, Issue:4 Topics: Aged; Anticoagulants; Aspirin; Atherosclerosis; Cardiology; Cardiovascular Diseases; Carotid Arteries; Carotid Artery Diseases; Clopidogrel; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Revascularization; Platelet Aggregation Inhibitors; Risk; Rivaroxaban	2019
High on-treatment platelet reactivity in peripheral endovascular procedures. Cardiovascular and interventional radiology, 2014, Volume: 37, Issue:3 Topics: Aspirin; Atherosclerosis; Blood Platelets; Clopidogrel; Endovascular Procedures; Humans; Peripheral Arterial Disease; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine	2014
Use of antiplatelet agents in patients with atherosclerotic disease. Postgraduate medicine, 2013, Volume: 125, Issue:5 Topics: Acute Coronary Syndrome; Adenosine; Aged; Aspirin; Atherosclerosis; Clopidogrel; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Risk Factors; Thiophenes; Ticagrelor; Ticlopidine	2013
Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: A review of the evidence. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2015, Oct-01, Volume: 72, Issue:19 Topics: Aspirin; Atherosclerosis; Blood Platelets; Clopidogrel; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Secondary Prevention; Severity of Illness Index; Stroke; Ticlopidine; Time Factors	2015
Genetic polymorphisms influence on the response to clopidogrel in peripheral artery disease patients following percutaneous transluminal angioplasty. Pharmacogenomics, 2016, Volume: 17, Issue:12 Topics: Aged; Angioplasty; Atherosclerosis; ATP Binding Cassette Transporter, Subfamily B; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Genotype; Graft Occlusion, Vascular; Humans; Lower Extremity; Male; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Spain; Ticlopidine; Treatment Outcome	2016
Clinical implications of aspirin resistance. Thrombosis and haemostasis, 2008, Volume: 100, Issue:3 Topics: Aspirin; Atherosclerosis; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Drug Resistance; Humans; Ischemia; Research Design; Stroke; Thrombosis; Ticlopidine; Treatment Outcome	2008
Antiplatelet drugs in cardiological practice: established strategies and new developments. Vascular health and risk management, 2008, Volume: 4, Issue:3 Topics: Atherosclerosis; Clopidogrel; Drug-Eluting Stents; Humans; Piperazines; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prasugrel Hydrochloride; Purinergic P2 Receptor Antagonists; Pyridines; Receptors, Thromboxane; Signal Transduction; Thiophenes; Thrombosis; Ticlopidine	2008
Combination antiplatelet therapy in patients with peripheral arterial disease: is the best therapy aspirin, clopidogrel, or both? Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2009, Jul-01, Volume: 74 Suppl 1 Topics: Aspirin; Atherosclerosis; Clopidogrel; Drug Resistance; Drug Therapy, Combination; Evidence-Based Medicine; Hemodynamics; Hemorrhage; Humans; Ischemia; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Risk Assessment; Thrombosis; Ticlopidine; Treatment Outcome	2009
Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy. Journal of the neurological sciences, 2009, Sep-15, Volume: 284, Issue:1-2 Topics: Adult; Aged; Aged, 80 and over; Aspirin; Atherosclerosis; Brain Ischemia; Clinical Trials as Topic; Clopidogrel; Confounding Factors, Epidemiologic; Decision Making; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Evidence-Based Medicine; Female; Follow-Up Studies; Hemorrhage; Humans; Ischemic Attack, Transient; Male; Middle Aged; Multicenter Studies as Topic; Patient Selection; Platelet Aggregation Inhibitors; Research Design; Secondary Prevention; Ticlopidine	2009
Review of prasugrel for the secondary prevention of atherothrombosis. Journal of managed care pharmacy : JMCP, 2009, Volume: 15, Issue:5 Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Atherosclerosis; Clopidogrel; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Randomized Controlled Trials as Topic; Risk Factors; Thiophenes; Thrombosis; Ticlopidine	2009
Ticagrelor: the first reversibly binding oral P2Y12 receptor antagonist. Cardiovascular therapeutics, 2009,Winter, Volume: 27, Issue:4 Topics: Acute Coronary Syndrome; Adenosine; Adenosine Diphosphate; Animals; Atherosclerosis; Clinical Trials as Topic; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Ticagrelor; Ticlopidine; Vasoconstriction	2009
Platelet adenosine diphosphate P2Y12 receptor antagonism: benefits and limitations of current treatment strategies and future directions. Revista espanola de cardiologia, 2010, Volume: 63, Issue:1 Topics: Atherosclerosis; Clopidogrel; Forecasting; Humans; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Thrombosis; Ticlopidine	2010
Combination antithrombotic therapies. Circulation, 2010, Feb-02, Volume: 121, Issue:4 Topics: Aspirin; Atherosclerosis; Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Pyridines; Thrombosis; Ticlopidine	2010
Therapeutic approaches in arterial thrombosis. Journal of thrombosis and haemostasis : JTH, 2005, Volume: 3, Issue:8 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Atherosclerosis; Blood Platelets; Clopidogrel; Coronary Thrombosis; Disease Models, Animal; Disease Progression; Fibrinolytic Agents; Humans; Mice; Models, Biological; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines; Risk; Signal Transduction; Thrombosis; Ticlopidine; Time Factors	2005
Masterclass series in peripheral arterial disease. Antiplatelet therapy for peripheral arterial disease and claudication. Vascular medicine (London, England), 2006, Volume: 11, Issue:1 Topics: Aspirin; Atherosclerosis; Clopidogrel; Drug Therapy, Combination; Humans; Intermittent Claudication; Lower Extremity; Meta-Analysis as Topic; Peripheral Vascular Diseases; Phthalic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Ticlopidine	2006
MATCH results: implications for the internist. The American journal of medicine, 2006, Volume: 119, Issue:6 Topics: Aspirin; Atherosclerosis; Clopidogrel; Controlled Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Europe; Hemorrhage; Humans; Ischemic Attack, Transient; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Thrombosis; Ticlopidine; Treatment Failure; United States	2006
[Atheromatosis of the thoracic aorta and risk of stroke]. Giornale italiano di cardiologia (2006), 2006, Volume: 7, Issue:5 Topics: Anticoagulants; Aorta, Thoracic; Aortic Diseases; Aspirin; Atherosclerosis; Clopidogrel; Controlled Clinical Trials as Topic; Echocardiography, Transesophageal; Fibrinolytic Agents; Follow-Up Studies; Humans; Hypolipidemic Agents; Meta-Analysis as Topic; Odds Ratio; Platelet Aggregation Inhibitors; Prognosis; Recurrence; Risk Factors; Stroke; Ticlopidine; Time Factors; Warfarin	2006
Aortic arch atheroma and the risk of stroke. Current atherosclerosis reports, 2006, Volume: 8, Issue:4 Topics: Aorta, Thoracic; Aspirin; Atherosclerosis; Clopidogrel; History, 18th Century; Humans; Risk Factors; Stroke; Ticlopidine	2006
Secondary prevention of stroke and transient ischemic attack: is more platelet inhibition the answer? Circulation, 2007, Mar-27, Volume: 115, Issue:12 Topics: Aspirin; Atherosclerosis; Cilostazol; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Dipyridamole; Disease Susceptibility; Drug Interactions; Drug Therapy, Combination; Dyslipidemias; Hemorrhage; Humans; Ischemic Attack, Transient; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Stroke; Tetrazoles; Ticlopidine; Treatment Outcome; Vasodilator Agents	2007
Variable platelet response to aspirin and clopidogrel in atherothrombotic disease. Circulation, 2007, Apr-24, Volume: 115, Issue:16 Topics: Adenosine Diphosphate; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atherosclerosis; Biomarkers; Biotransformation; Blood Coagulation Tests; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Drug Interactions; Drug Resistance; Hemorrhage; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Randomized Controlled Trials as Topic; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Thrombosis; Thromboxane A2; Thromboxane B2; Ticlopidine; Treatment Failure	2007
Clinical aspects of platelet inhibitors and thrombus formation. Circulation research, 2007, May-11, Volume: 100, Issue:9 Topics: Aspirin; Atherosclerosis; Blood Platelets; Cardiovascular Diseases; Cilostazol; Clopidogrel; Dipyridamole; Drug Resistance; Humans; Pentanoic Acids; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2 Receptor Antagonists; Pyridines; Receptor, PAR-1; Stents; Tetrazoles; Thrombosis; Thromboxanes; Ticlopidine	2007
Antiplatelet therapy for atherothrombotic disease: an update for the primary care physician. Mayo Clinic proceedings, 2007, Volume: 82, Issue:5 Topics: Anticoagulants; Aspirin; Atherosclerosis; Clopidogrel; Drug Therapy, Combination; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Primary Health Care; Recurrence; Risk Assessment; Stroke; Syndrome; Thrombosis; Ticlopidine	2007
Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease. Vascular medicine (London, England), 2007, Volume: 12, Issue:2 Topics: Angina, Unstable; Aspirin; Atherosclerosis; Biomarkers; Blood Platelets; Clopidogrel; Humans; Inflammation; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Stroke; Thrombosis; Ticlopidine	2007
Antiplatelet therapy for stroke prevention. Current atherosclerosis reports, 2007, Volume: 9, Issue:4 Topics: Anticoagulants; Aspirin; Atherosclerosis; Atrial Fibrillation; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine	2007
Role of antiplatelet agents in the primary and secondary prevention of atherothrombotic events in high risk-patients. Southern medical journal, 2008, Volume: 101, Issue:3 Topics: Aspirin; Atherosclerosis; Clinical Trials as Topic; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Ischemia; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Thrombosis; Ticlopidine	2008
Antiplatelet therapy for vascular interventions. Perspectives in vascular surgery and endovascular therapy, 2008, Volume: 20, Issue:1 Topics: Angioplasty, Balloon; Aspirin; Atherosclerosis; Clopidogrel; Drug Therapy, Combination; Endarterectomy, Carotid; Humans; Inguinal Canal; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Vascular Surgical Procedures	2008

Trials

25 trial(s) available for clopidogrel and Atherogenesis

Article	Year
Impact of evolocumab on the pharmacodynamic profiles of clopidogrel in patients with atherosclerotic cardiovascular disease: a randomised, double-blind, placebo-controlled study. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2023, Mar-20, Volume: 18, Issue:15 Topics: Antibodies, Monoclonal; Anticholesteremic Agents; Atherosclerosis; Cardiovascular Diseases; Cholesterol, LDL; Clopidogrel; Double-Blind Method; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Proprotein Convertase 9; Prospective Studies; Treatment Outcome	2023
Rationale and design of a randomised double-blind 2×2 factorial trial comparing the effect of a 3-month intensive statin and antiplatelet therapy for patients with acute mild ischaemic stroke or high-risk TIA with intracranial or extracranial atherosclero Stroke and vascular neurology, 2023, Volume: 8, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Aspirin; Atherosclerosis; Atorvastatin; Brain Ischemia; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Ischemic Stroke; Middle Aged; Platelet Aggregation Inhibitors; Stroke	2023
Dual antiplatelet Use for extended period taRgeted to AcuTe ischemic stroke with presumed atherosclerotic OrigiN (DURATION) trial: Rationale and design. International journal of stroke : official journal of the International Stroke Society, 2023, Volume: 18, Issue:8 Topics: Aspirin; Atherosclerosis; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Ischemic Stroke; Platelet Aggregation Inhibitors; Prospective Studies; Stroke; Treatment Outcome	2023
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients Treated With P2Y12 Inhibitors. Journal of the American Heart Association, 2023, 10-17, Volume: 12, Issue:20 Topics: Acute Coronary Syndrome; Aspirin; Atherosclerosis; Cardiovascular Diseases; Clopidogrel; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Secondary Prevention; Ticlopidine	2023
Pharmacokinetics and Bioequivalence of Clopidogrel Hydrogen Sulfate Tablets in Fed and Fasted Conditions: An Open-Label, Randomized, Semireplicated Crossover Study in Healthy Chinese Volunteers. Clinical pharmacology in drug development, 2020, Volume: 9, Issue:7 Topics: Acute Coronary Syndrome; Administration, Oral; Adult; Area Under Curve; Asian People; Atherosclerosis; Chromatography, Liquid; Clopidogrel; Coronary Restenosis; Cross-Over Studies; Drug Compounding; Fasting; Female; Healthy Volunteers; Humans; Male; Platelet Aggregation Inhibitors; Stents; Tandem Mass Spectrometry; Therapeutic Equivalency; Thrombosis	2020
Efficacy and Safety of Prasugrel by Stroke Subtype: A Sub-Analysis of the PRASTRO-I Randomized Controlled Trial. Journal of atherosclerosis and thrombosis, 2021, Feb-01, Volume: 28, Issue:2 Topics: Arteries; Arteriosclerosis; Atherosclerosis; Clopidogrel; Drug Monitoring; Female; Hemorrhage; Humans; Ischemic Stroke; Male; Middle Aged; Organ Size; Outcome and Process Assessment, Health Care; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Treatment Outcome	2021
Legumain in Acute Coronary Syndromes: A Substudy of the PLATO (Platelet Inhibition and Patient Outcomes) Trial. Journal of the American Heart Association, 2020, Volume: 9, Issue:17 Topics: Acute Coronary Syndrome; Aged; Atherosclerosis; Case-Control Studies; Clopidogrel; Cysteine Endopeptidases; Cysteine Proteases; Death; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Ticagrelor; Treatment Outcome	2020
Cost-effectiveness of ticagrelor versus clopidogrel for the prevention of atherothrombotic events in adult patients with acute coronary syndrome in Germany. Clinical research in cardiology : official journal of the German Cardiac Society, 2013, Volume: 102, Issue:6 Topics: Acute Coronary Syndrome; Adenosine; Adult; Atherosclerosis; Clopidogrel; Cost-Benefit Analysis; Decision Trees; Double-Blind Method; Drugs, Generic; Follow-Up Studies; Germany; Humans; Markov Chains; Models, Economic; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Quality-Adjusted Life Years; Thrombosis; Ticagrelor; Ticlopidine; Time Factors	2013
Impact of smoking on long-term outcomes in patients with atherosclerotic vascular disease treated with aspirin or clopidogrel: insights from the CAPRIE trial (Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events). Journal of the American College of Cardiology, 2014, Mar-04, Volume: 63, Issue:8 Topics: Aspirin; Atherosclerosis; Brain Ischemia; Clopidogrel; Female; Humans; Male; Risk Factors; Single-Blind Method; Smoking; Ticlopidine; Time Factors; Treatment Outcome	2014
Clopidogrel plus aspirin prevents early neurologic deterioration and improves 6-month outcome in patients with acute large artery atherosclerosis stroke. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2015, Volume: 21, Issue:5 Topics: Acute Disease; Aged; Aspirin; Atherosclerosis; Clopidogrel; Female; Humans; Male; Nervous System Diseases; Platelet Aggregation; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Treatment Outcome	2015
Recurrent Ischemic Lesions After Acute Atherothrombotic Stroke: Clopidogrel Plus Aspirin Versus Aspirin Alone. Stroke, 2016, Volume: 47, Issue:9 Topics: Aged; Aspirin; Atherosclerosis; Brain; Brain Ischemia; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Thrombosis; Ticlopidine	2016
Histamine-2 Receptor Antagonist Cannot Prevent Recurrent Peptic Ulcers in Patients With Atherosclerotic Diseases Who Receive Platelet ADP Receptor Antagonist Monotherapy: A Randomized-Controlled, Double-Blind, and Double-Dummy Trial. The American journal of gastroenterology, 2017, Volume: 112, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Atherosclerosis; Clopidogrel; Double-Blind Method; Famotidine; Female; Helicobacter Infections; Histamine H2 Antagonists; Humans; Male; Middle Aged; Peptic Ulcer; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Purinergic P2Y Receptor Antagonists; Recurrence; Ticlopidine; Treatment Outcome	2017
Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) study. American heart journal, 2009, Volume: 157, Issue:4 Topics: Aged; Atherosclerosis; Cause of Death; Clopidogrel; Double-Blind Method; Ethnicity; Female; Follow-Up Studies; Hemorrhage; Humans; Incidence; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation Inhibitors; Prognosis; Prospective Studies; Risk Factors; Stroke; Ticlopidine; Time Factors; United States	2009
Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations in P2RY12, P2RY1, and ITGB3. Platelets, 2009, Volume: 20, Issue:5 Topics: Adenosine; Adenosine Diphosphate; Area Under Curve; Atherosclerosis; Clopidogrel; Dose-Response Relationship, Drug; Humans; Integrin beta3; Pharmacogenetics; Platelet Aggregation; Polymorphism, Single Nucleotide; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Ticagrelor; Ticlopidine	2009
PROCLAIM: pilot study to examine the effects of clopidogrel on inflammatory markers in patients with metabolic syndrome receiving low-dose aspirin. Texas Heart Institute journal, 2009, Volume: 36, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Aspirin; Atherosclerosis; Biomarkers; C-Reactive Protein; CD40 Ligand; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Inflammation Mediators; Least-Squares Analysis; Male; Metabolic Syndrome; Middle Aged; Natriuretic Peptide, Brain; P-Selectin; Peptide Fragments; Pilot Projects; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome; United States; Young Adult	2009
Esomeprazole with clopidogrel reduces peptic ulcer recurrence, compared with clopidogrel alone, in patients with atherosclerosis. Gastroenterology, 2011, Volume: 140, Issue:3 Topics: Aged; Aged, 80 and over; Aryl Hydrocarbon Hydroxylases; Atherosclerosis; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Interactions; Endoscopy, Gastrointestinal; Esomeprazole; Female; Genotype; Humans; Male; Middle Aged; Peptic Ulcer; Phenotype; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Proton Pump Inhibitors; Risk Assessment; Secondary Prevention; Taiwan; Ticlopidine; Time Factors; Treatment Outcome	2011
High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: a substudy from the CHARISMA trial. Heart (British Cardiac Society), 2011, Volume: 97, Issue:8 Topics: Aged; Aspirin; Atherosclerosis; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Epidemiologic Methods; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome	2011
High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention. Heart (British Cardiac Society), 2011, Volume: 97, Issue:12 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Atherosclerosis; Clopidogrel; Drug Therapy, Combination; Female; Graft Occlusion, Vascular; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Risk Factors; Stents; Stroke; Thrombosis; Ticlopidine; Treatment Outcome	2011
Platelet response to aspirin and clopidogrel in patients with peripheral atherosclerosis. Platelets, 2011, Volume: 22, Issue:7 Topics: Aged; Aspirin; Atherosclerosis; Blood Platelets; Clopidogrel; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticlopidine; Treatment Outcome	2011
Bleeding, mortality, and antiplatelet therapy: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. American heart journal, 2011, Volume: 162, Issue:1 Topics: Aged; Atherosclerosis; Cause of Death; Clopidogrel; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Global Health; Hemorrhage; Humans; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation Inhibitors; Prognosis; Prospective Studies; Risk Factors; Survival Rate; Thrombosis; Ticlopidine	2011
The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study. European heart journal, 2012, Volume: 33, Issue:17 Topics: Aryl Hydrocarbon Hydroxylases; Atherosclerosis; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Genotype; Hemorrhage; Heterozygote; Humans; Ischemia; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Stroke; Thrombosis; Ticlopidine	2012
Risk of intracerebral hemorrhage in patients with cerebral microbleeds undergoing endovascular intervention. Stroke, 2012, Volume: 43, Issue:6 Topics: Aged; Aged, 80 and over; Aspirin; Atherosclerosis; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Endovascular Procedures; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Stroke; Ticlopidine	2012
Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin. European heart journal, 2006, Volume: 27, Issue:9 Topics: Adenosine; Administration, Oral; Adult; Aged; Aged, 80 and over; Aspirin; Atherosclerosis; Bleeding Time; Clopidogrel; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Postmenopause; Ticagrelor; Ticlopidine	2006
Oral anticoagulant and antiplatelet therapy and peripheral arterial disease. The New England journal of medicine, 2007, Jul-19, Volume: 357, Issue:3 Topics: Acenocoumarol; Administration, Oral; Anticoagulants; Aspirin; Atherosclerosis; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Female; Follow-Up Studies; Hemorrhage; Humans; Incidence; Male; Middle Aged; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Ticlopidine; Warfarin	2007
An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial. European heart journal, 2007, Volume: 28, Issue:18 Topics: Aged; Aspirin; Atherosclerosis; Cardiovascular Diseases; Clopidogrel; Disease-Free Survival; Drug Therapy, Combination; Epidemiologic Methods; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Stroke; Ticlopidine	2007

Other Studies

46 other study(ies) available for clopidogrel and Atherogenesis

Article	Year
Silibinin augments the effect of clopidogrel on atherosclerosis in diabetic ApoE deficiency mice. Clinical hemorheology and microcirculation, 2022, Volume: 80, Issue:4 Topics: Animals; Apolipoproteins E; Atherosclerosis; Clopidogrel; Diabetes Mellitus, Experimental; Mice; Mice, Inbred C57BL; Mice, Knockout; Silybin	2022
Dual Antiplatelet Therapy Plus Argatroban Prevents Early Neurological Deterioration in Branch Atherosclerosis Disease. Stroke, 2022, Volume: 53, Issue:1 Topics: Arginine; Aspirin; Atherosclerosis; Brain Ischemia; Clopidogrel; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Stroke; Sulfonamides; Ticlopidine	2022
[Cerebral Infarction with Diffuse and Severe Atherosclerosis of The Main Cerebral Artery and Recurrent Infarction Despite Multiple Antiplatelet Agents: Management for Acute Stroke Patients]. Brain and nerve = Shinkei kenkyu no shinpo, 2022, Volume: 74, Issue:5 Topics: Atherosclerosis; Cerebral Arteries; Cerebral Infarction; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Stroke; Treatment Outcome	2022
[Risk Factors of Clopidogrel Resistance in the Elderly Patients with Atherosclerotic Cardiovascular Disease]. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 2023, Volume: 45, Issue:1 Topics: Aged; Aged, 80 and over; Atherosclerosis; Cardiovascular Diseases; Cholesterol, LDL; Clopidogrel; Female; Humans; Risk Factors	2023
Dual Antiplatelet Therapies and Causes in Minor Stroke or Transient Ischemic Attack: A Prespecified Analysis in the CHANCE-2 Trial. Stroke, 2023, Volume: 54, Issue:9 Topics: Aspirin; Atherosclerosis; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Stroke; Ticagrelor; Treatment Outcome	2023
Age-dependent association of CYP2C19 polymorphisms with clinical outcome of clopidogrel therapy in minor stroke patients with large-artery atherosclerosis. European journal of clinical pharmacology, 2020, Volume: 76, Issue:9 Topics: Age Factors; Aged; Alleles; Atherosclerosis; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Prospective Studies; Stroke; Treatment Outcome	2020
Antithrombotic Therapy: Prevention and Treatment of Atherosclerosis and Atherothrombosis. Handbook of experimental pharmacology, 2022, Volume: 270 Topics: Animals; Aspirin; Atherosclerosis; Clopidogrel; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors	2022
Is a variability of platelet inhibitory effect of anti-platelet agents important for predicting new lesion in atherothrombotic stroke? International journal of stroke : official journal of the International Stroke Society, 2018, Volume: 13, Issue:6 Topics: Aged; Aged, 80 and over; Aspirin; Atherosclerosis; Blood Platelets; Clopidogrel; Diffusion Magnetic Resonance Imaging; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Prospective Studies; Thrombosis	2018
Peroneal artery entrapment syndrome (PRAES): a rare cause of ischaemic toes. BMJ case reports, 2019, Jan-28, Volume: 12, Issue:1 Topics: Aged; Atherosclerosis; Clopidogrel; Constriction, Pathologic; Diagnosis, Differential; Embolism; Humans; Leg; Magnetic Resonance Angiography; Male; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Syndrome; Tibial Arteries; Toes	2019
Dual Versus Mono Antiplatelet Therapy in Large Atherosclerotic Stroke. Stroke, 2019, Volume: 50, Issue:5 Topics: Aged; Aged, 80 and over; Aspirin; Atherosclerosis; Brain Ischemia; Clopidogrel; Dual Anti-Platelet Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Registries; Retrospective Studies; Stroke	2019
Ticagrelor induces paraoxonase-1 (PON1) and better protects hypercholesterolemic mice against atherosclerosis compared to clopidogrel. PloS one, 2019, Volume: 14, Issue:6 Topics: Acute Coronary Syndrome; Animals; Aryldialkylphosphatase; Atherosclerosis; Blood Platelets; Clopidogrel; Cross-Sectional Studies; Hypercholesterolemia; Male; Mice; Mice, Inbred C57BL; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Purinergic P2Y Receptor Antagonists; Receptors, LDL; Ticagrelor	2019
Cigarette smoking and antiplatelet effects of aspirin monotherapy versus clopidogrel monotherapy in patients with atherosclerotic disease: results of a prospective pharmacodynamic study. Journal of cardiovascular translational research, 2014, Volume: 7, Issue:1 Topics: Adult; Aged; Aspirin; Atherosclerosis; Biomarkers; Blood Platelets; Clopidogrel; Cotinine; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Signal Transduction; Smoking; Thrombelastography; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome	2014
Antiatherosclerotic potential of clopidogrel: antioxidant and anti-inflammatory approaches. BioMed research international, 2013, Volume: 2013 Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Atherosclerosis; Chemokine CCL2; Clopidogrel; Gene Expression Regulation; Humans; Interleukin-17; Rabbits; Ticlopidine; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1	2013
Vessel wall, not platelet, P2Y12 potentiates early atherogenesis. Cardiovascular research, 2014, Jun-01, Volume: 102, Issue:3 Topics: Adenosine; Animals; Apolipoproteins E; Atherosclerosis; Blood Platelets; Blood Vessels; Clopidogrel; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; P-Selectin; Receptors, Purinergic P2Y12; Ticagrelor; Ticlopidine	2014
Human neutrophil α-defensins are associated with adenosine diphosphate-inducible neutrophil-platelet aggregate formation and response to clopidogrel in patients with atherosclerosis. Translational research : the journal of laboratory and clinical medicine, 2014, Volume: 164, Issue:3 Topics: Adenosine Diphosphate; alpha-Defensins; Atherosclerosis; C-Reactive Protein; Clopidogrel; Flow Cytometry; Humans; Interleukin-6; Neutrophils; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine	2014
Clopidogrel significantly lowers the development of atherosclerosis in ApoE-deficient mice in vivo. Heart and vessels, 2016, Volume: 31, Issue:5 Topics: Animals; Aorta, Thoracic; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Biomarkers; Chemokine CCL2; Clopidogrel; Disease Models, Animal; Disease Progression; E-Selectin; Gene Expression Regulation; Genetic Predisposition to Disease; Lipids; Lymphokines; Mice, Inbred C57BL; Mice, Knockout; P-Selectin; Phenotype; Plaque, Atherosclerotic; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet-Derived Growth Factor; RNA, Messenger; Ticlopidine; Time Factors; Vascular Remodeling	2016
Effect of Fibrinogen on Platelet Reactivity Measured by the VerifyNow P2Y12 Assay. Biochemistry. Biokhimiia, 2016, Volume: 81, Issue:5 Topics: Atherosclerosis; Blood Platelets; Clopidogrel; Fibrinogen; Humans; Immobilized Proteins; Nephelometry and Turbidimetry; Platelet Aggregation; Platelet Function Tests; Receptors, Purinergic P2Y12; Regression Analysis; Ticlopidine	2016
Anti-atherosclerotic effect of atorvastatin and clopidogrel alone and in combination in rats. Indian journal of experimental biology, 2008, Volume: 46, Issue:10 Topics: Animals; Atherosclerosis; Atorvastatin; Clopidogrel; Diet, Atherogenic; Drug Interactions; Female; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Platelet Aggregation Inhibitors; Pyrroles; Rats; Rats, Wistar; Ticlopidine	2008
Facts and controversies of aspirin and clopidogrel therapy. American heart journal, 2009, Volume: 157, Issue:3 Topics: Acute Coronary Syndrome; Aspirin; Atherosclerosis; Blood Platelets; Brain Ischemia; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Myocardial Infarction; Piperazines; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Prasugrel Hydrochloride; Purinergic P2 Receptor Antagonists; Thiophenes; Ticlopidine	2009
Athero-embolic isolated splenic infarction following left cardiac catheterization. Journal of cardiovascular medicine (Hagerstown, Md.), 2009, Volume: 10, Issue:3 Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aortic Aneurysm, Abdominal; Aspirin; Atherosclerosis; Cardiac Catheterization; Clopidogrel; Coronary Stenosis; Embolism, Cholesterol; Heparin; Humans; Infarction; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Spleen; Thrombosis; Ticlopidine; Tomography, X-Ray Computed; Treatment Outcome; Warfarin	2009
Clopidogrel attenuates atheroma formation and induces a stable plaque phenotype in apolipoprotein E knockout mice. Microvascular research, 2009, Volume: 77, Issue:3 Topics: Animals; Apolipoproteins E; Atherosclerosis; Cell Proliferation; Cells, Cultured; Clopidogrel; Disease Models, Animal; Endothelium, Vascular; Female; Fibrosis; Mice; Mice, Inbred C57BL; Mice, Knockout; Platelet Aggregation Inhibitors; Sinus of Valsalva; Spleen; Stem Cells; T-Lymphocytes, Regulatory; Ticlopidine	2009
[Pharmazie in unserer Zeit 4/2009]. Pharmazie in unserer Zeit, 2009, Volume: 38, Issue:4 Topics: Aspirin; Atherosclerosis; Clopidogrel; Drug Resistance; Humans; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prasugrel Hydrochloride; Purinergic P2 Receptor Antagonists; Thiophenes; Ticlopidine	2009
Medical treatment of patients with intracranial atherosclerotic disease. Journal of neuroimaging : official journal of the American Society of Neuroimaging, 2009, Volume: 19 Suppl 1 Topics: Anticoagulants; Aspirin; Atherosclerosis; Brain Ischemia; Cilostazol; Clopidogrel; Dipyridamole; Embolism; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Arteriosclerosis; Intracranial Thrombosis; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Risk Factors; Tetrazoles; Ticlopidine	2009
Effects of clopidogrel on vascular proliferation and apoptosis in an atherosclerotic rabbit model. Journal of cardiovascular pharmacology, 2010, Volume: 55, Issue:6 Topics: Animals; Apoptosis; Atherosclerosis; Atorvastatin; C-Reactive Protein; Catheterization; Clopidogrel; Endothelium, Vascular; Heptanoic Acids; Inflammation; Male; Platelet-Derived Growth Factor; Pyrroles; Rabbits; Random Allocation; Ticlopidine; Tunica Intima	2010
Late common iliac artery stent thrombosis in a patient with terminal malignancy. Cardiology, 2010, Volume: 115, Issue:4 Topics: Aged; Angiography; Aspirin; Atherosclerosis; Carcinoma, Renal Cell; Clopidogrel; Humans; Iliac Artery; Kidney Neoplasms; Male; Platelet Aggregation Inhibitors; Stents; Thrombosis; Ticlopidine	2010
Costs and consequences of clopidogrel versus aspirin for secondary prevention of ischaemic events in (high-risk) atherosclerotic patients in Sweden: a lifetime model based on the CAPRIE trial and high-risk CAPRIE subpopulations. Applied health economics and health policy, 2010, Volume: 8, Issue:4 Topics: Aged; Aspirin; Atherosclerosis; Clopidogrel; Cost-Benefit Analysis; Female; Humans; Male; Markov Chains; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Secondary Prevention; Sweden; Ticlopidine	2010
[Dental management of patients using anti agregant drugs: background, risks and clinical guidelines]. Refu'at ha-peh veha-shinayim (1993), 2009, Volume: 26, Issue:4 Topics: Atherosclerosis; Clopidogrel; Dentistry; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Factors; Thrombosis; Ticlopidine; Tooth Extraction	2009
Proton pump inhibitor co-therapy with clopidogrel: is there GI benefit or cardiovascular harm? Gastroenterology, 2011, Volume: 140, Issue:3 Topics: Atherosclerosis; Clopidogrel; Drug Interactions; Humans; Omeprazole; Peptic Ulcer; Platelet Aggregation; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Risk Assessment; Secondary Prevention; Ticlopidine; Time Factors; Treatment Outcome	2011
Clopidogrel use and short-term mortality after peptic ulcer bleeding: a population-based cohort study. American journal of therapeutics, 2013, Volume: 20, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Atherosclerosis; Clopidogrel; Cohort Studies; Denmark; Female; Humans; Male; Middle Aged; Peptic Ulcer Hemorrhage; Platelet Aggregation Inhibitors; Prognosis; Proportional Hazards Models; Registries; Ticlopidine	2013
Beneficial effect of anti-platelet therapies on atherosclerotic lesion formation assessed by phase-contrast X-ray CT imaging. The international journal of cardiovascular imaging, 2012, Volume: 28, Issue:5 Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Body Weight; Brachiocephalic Trunk; Cell Adhesion Molecules; Cholesterol, Dietary; Cilostazol; Clopidogrel; Collagen; Cytokines; Disease Models, Animal; Gene Expression Regulation; Immunohistochemistry; Inflammation Mediators; Lipids; Macrophages; Mice; Mice, Knockout; Plaque, Atherosclerotic; Platelet Aggregation Inhibitors; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Ticlopidine; Tomography, X-Ray Computed	2012
Dose-related effect of statins in venous thrombosis risk reduction. The American journal of medicine, 2011, Volume: 124, Issue:9 Topics: Aged; Aspirin; Atherosclerosis; Cerebral Infarction; Clopidogrel; Cohort Studies; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Proportional Hazards Models; Pulmonary Embolism; Retrospective Studies; Risk Reduction Behavior; Ticlopidine; Venous Thromboembolism	2011
Anti-inflammatory and anti-thrombotic intervention strategies using atorvastatin, clopidogrel and knock-down of CD40L do not modify radiation-induced atherosclerosis in ApoE null mice. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2011, Volume: 101, Issue:1 Topics: Animals; Anti-Inflammatory Agents; Apolipoproteins E; Atherosclerosis; Atorvastatin; Carotid Arteries; CD40 Antigens; Clopidogrel; Disease Models, Animal; Heptanoic Acids; Immunohistochemistry; Mice; Mice, Inbred C57BL; Mice, Knockout; Platelet Aggregation Inhibitors; Pyrroles; Radiation Dosage; Radiation Injuries, Experimental; Random Allocation; Reference Values; Statistics, Nonparametric; Ticlopidine	2011
Insufficient platelet inhibition is related to silent embolic cerebral infarctions after coronary angiography. Stroke, 2012, Volume: 43, Issue:3 Topics: Aged; Aspirin; Atherosclerosis; Basilar Artery; Carotid Arteries; Cerebral Infarction; Clopidogrel; Coronary Angiography; Data Interpretation, Statistical; Diffusion Magnetic Resonance Imaging; Drug Resistance; Female; Hemoglobins; Humans; Intracranial Embolism; Leukocyte Count; Logistic Models; Magnetic Resonance Angiography; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Ticlopidine; Vertebral Artery	2012
Clopidogrel versus aspirin in patients with atherothrombosis: a CAPRIE-based cost-effectiveness model for Greece. Applied health economics and health policy, 2012, Sep-01, Volume: 10, Issue:5 Topics: Aspirin; Atherosclerosis; Cardiovascular Diseases; Clopidogrel; Cost-Benefit Analysis; Greece; Humans; Models, Economic; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Secondary Prevention; Thrombosis; Ticlopidine; Treatment Outcome	2012
Platelets in vascular disease. Clinical hemorheology and microcirculation, 2013, Volume: 53, Issue:1-2 Topics: Aspirin; Atherosclerosis; Blood Platelets; Clopidogrel; Hemostasis; Humans; Plaque, Atherosclerotic; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine; Vascular Diseases	2013
Effects of low-dose acetylsalicylic acid and atherosclerotic vascular diseases on the outcome in patients with severe sepsis or septic shock. Platelets, 2013, Volume: 24, Issue:6 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atherosclerosis; Blood Coagulation; Clopidogrel; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Sepsis; Shock, Septic; Ticlopidine; Treatment Outcome	2013
[Inhibitory effects of aspirin, clopidogrel, and their combination on the progression of atherosclerosis in rabbits]. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 2005, Volume: 27, Issue:1 Topics: Animals; Aorta; Aspirin; Atherosclerosis; C-Reactive Protein; Cell Count; Clopidogrel; Cyclooxygenase Inhibitors; Drug Synergism; Macrophages; Male; Myocytes, Smooth Muscle; Platelet Aggregation Inhibitors; Rabbits; Random Allocation; Ticlopidine	2005
Prevention of carotid artery restenosis after sirolimus-coated stent implantation in pigs. Stroke, 2006, Volume: 37, Issue:2 Topics: Alloys; Angioplasty, Balloon, Coronary; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atherosclerosis; Carotid Arteries; Clopidogrel; Coronary Angiography; Coronary Restenosis; Disease Models, Animal; Male; Polymers; Sirolimus; Stents; Swine; Ticlopidine; Time Factors; Ultrasonics	2006
[Accelerated atheroma with prednisone and clopidogrel]. Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:3 Pt 1 Topics: Aged; Atherosclerosis; Carotid Stenosis; Clopidogrel; Endarterectomy; Giant Cell Arteritis; Glucocorticoids; Humans; Inflammation; Male; Necrosis; Platelet Aggregation Inhibitors; Prednisone; Ticlopidine	2006
CHARISMA: the antiplatelet saga continues. Stroke, 2006, Volume: 37, Issue:9 Topics: Atherosclerosis; Clinical Trials as Topic; Clopidogrel; Humans; Ischemia; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine; Treatment Failure	2006
Effect of clopidogrel on the inflammatory progression of early atherosclerosis in rabbits model. Atherosclerosis, 2007, Volume: 194, Issue:2 Topics: Animals; Aspirin; Atherosclerosis; Atorvastatin; Chemokine CCL2; Clopidogrel; Diet, Atherogenic; Disease Models, Animal; Femoral Artery; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Intercellular Adhesion Molecule-1; Male; P-Selectin; Platelet Aggregation Inhibitors; Pyrroles; Rabbits; Ticlopidine; Vascular Cell Adhesion Molecule-1	2007
Letter by Fisher and Johns regarding article, "Variable platelet response to aspirin and clopidogrel in atherothrombotic disease". Circulation, 2007, Nov-06, Volume: 116, Issue:19 Topics: Aspirin; Atherosclerosis; Blood Platelets; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Tablets, Enteric-Coated; Ticlopidine	2007
Clopidogrel versus aspirin in patients with atherothrombosis: CAPRIE-based calculation of cost-effectiveness for Germany. Current medical research and opinion, 2008, Volume: 24, Issue:1 Topics: Aged; Aged, 80 and over; Aspirin; Atherosclerosis; Clopidogrel; Cohort Studies; Coronary Thrombosis; Cost-Benefit Analysis; Germany; Humans; Models, Econometric; Myocardial Infarction; Platelet Aggregation Inhibitors; Survival Analysis; Ticlopidine; Treatment Outcome	2008
Effect of chronic treatment with acetylsalicylic acid and clopidogrel on atheroprogression and atherothrombosis in ApoE-deficient mice in vivo. Thrombosis and haemostasis, 2008, Volume: 99, Issue:1 Topics: Animals; Aorta; Apolipoproteins E; Aspirin; Atherosclerosis; Blood Platelets; Carotid Arteries; Cholesterol, Dietary; Clopidogrel; Disease Models, Animal; Disease Progression; Drug Administration Schedule; Drug Therapy, Combination; Endothelial Cells; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Fluorescence; Microscopy, Video; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Rupture; Thrombosis; Ticlopidine; Time Factors	2008
Platelet activation and atherothrombosis. The New England journal of medicine, 2008, Apr-10, Volume: 358, Issue:15 Topics: Acute Coronary Syndrome; Aspirin; Atherosclerosis; Clopidogrel; Drug Therapy, Combination; Humans; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine; Vascular Diseases	2008
Antithrombotic therapy in peripheral arterial disease. Cardiology clinics, 2008, Volume: 26, Issue:2 Topics: Anticoagulants; Aspirin; Atherosclerosis; Cilostazol; Clopidogrel; Comorbidity; Diabetic Angiopathies; Humans; Hypertension; Intermittent Claudication; Pentoxifylline; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Risk Factors; Smoking; Tetrazoles; Thrombolytic Therapy; Ticlopidine	2008